Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 30 Jun 2025 for Arvinas, INC.. Read the official filing
Filing timeline
BuySaleSunil Agarwal
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Sunil Agarwal: trading record in brief
This profile gathers the share dealings of Sunil Agarwal across 3 companies, led by Arvinas, Inc., Ultragenyx Pharmaceutical Inc. and Sana Biotechnology, Inc. Between 19 January 2016 and 25 June 2025, the trades on record add up to 6 filings.
The open-market record consists of 2 sales worth €1.3M, with no purchase. The amount is not disclosed for 1 filing. Other entries cover 4 share grants.
On 30 June 2025 came the latest disclosure, a share grant in Arvinas, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Sunil Agarwal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
16,025 shares0Common StockSEC:0001655759-25-000126:0
5,899 shares0Common StockSEC:0001655759-24-000084:0
8,242 shares0Common StockSEC:0001655759-23-000059:0
58,373 shares@ US$26.0695100.0% of flowCommon StockSEC:0001562180-21-005999:0
456 sharesCommon StockSEC:0001562180-16-001371:0
585 sharesCommon StockSEC:0001562180-16-001371:1
6 of 6 declarations
